Westchester Capital Management (New York)’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Westchester Capital Management (New York)’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-439,000	Closed	-$4.4M	–	497
2022 Q4	$4.4M	Buy	439,000 +200,000	+84%	+$2M	0.12%	211
2022 Q3	$2.37M	Hold	239,000	–	–	0.07%	255
2022 Q2	$2.34M	Hold	239,000	–	–	0.07%	224
2022 Q1	$2.34M	Hold	239,000	–	–	0.06%	221
2021 Q4	$2.32M	Hold	239,000	–	–	0.07%	194
2021 Q3	$2.33M	Hold	239,000	–	–	0.07%	156
2021 Q2	$2.31M	Buy	+239,000	New	+$2.34M	0.05%	143

Westchester Capital Management (New York)'s MSAC Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 439,000 shares — an estimated $4.4M sold.

Westchester Capital Management (New York) first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $4.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Westchester Capital Management (New York) reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 439,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $4.4M.
Westchester Capital Management (New York) first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Westchester Capital Management (New York)'s Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $4.4M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.